Struggling to manage your Ulcerative Colitis?

You may be eligible to participate in a clinical trial for a new treatment

Struggling to manage your Ulcerative Colitis? You may be eligible to participate in a clinical trial for a new treatment

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Ulcerative Colitis Clinical Trial
NCT02819635 | Phase 3 | Interventional
AbbVie
Sponsored by
AbbVie

Struggling to manage your Ulcerative Colitis?

You may be eligible to participate in a clinical trial for a new treatment

Struggling to manage your Ulcerative Colitis? You may be eligible to participate in a clinical trial for a new treatment

Completed

Male & Female

16 - 75

Years old

This study has recruited 1302 Participants

Ulcerative Colitis is an inflammatory condition that affects the digestive track. For people with UC, it's symptoms can have a huge impact on their lives. There are several treatment options available for ulcerative colitis but they are not always effective for every patient. This clinical trial is evaluating a new treatment option for UC patients who have not responded well to other treatments.

Why should I participate?

All participants will receive study related treatments and procedures at no cost.

Who can participate?

Men and women who
-Are between the ages of 18-80
-Were diagnosed with Ulcerative Colitis
-Had an inadequate response to, loss of response to, or intolerance to corticosteroids, immunosuppressants, and/or biologic therapies